Literature DB >> 49294

Multiple specificities of mammalian blood group substances comparatively studied with human isoagglutinins and fractionated anti-H lectins.

J V Chuba, W J Kuhns, J D Oppenheim, M S Nachbar, R F Nigrelli.   

Abstract

Purified blood group-active substances derived from different pig, horse, baboon, Rhesus monkey and human tissues were quantitatively studied for their haemagglutination inhibiting potency with: (1) human IgM anti-A and anti-B; (2) human anti-Lea and anti-Leb; (3) Ulex europaeus extracts separated into lectin fractions with respective L-fucose-inhibitable ('anti-HF') and chitobiose-cellobiose-inhibitable ('anti-HC') combining sites. Irrespective of species origin, A and B blood group activity per milligram of purified material tended to be strikingly higher in substances low in, or devoid of, Lewis blood group activity. Most of the blood group substances displayed variable but about equally balanced amounts of Ulex anti-HF and anti-HC inhibiting activity. In contrast, pig submaxillary gland mucins displayed strikingly high levels of Ulex anti-HC inihibiting activity, even in the complete absence of Ulex anti-HF inhibiting activity. These serological findings are consistent with current biochemical concepts regarding the heterosaccharide microheterogeneity of blood group-active glycoproteins.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 49294      PMCID: PMC1445872     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  27 in total

1.  Effect of sialidase on blood group specificity of hog submaxillary glycoproteins.

Authors:  D Aminoff; M P. Morrow
Journal:  FEBS Lett       Date:  1970-07-03       Impact factor: 4.124

2.  Action of proteolytic enzymes on purified bovine submaxillary mucin.

Authors:  Y HASHIMOTO; S TSUIKI; K NISIZAWA; W PIGMAN
Journal:  Ann N Y Acad Sci       Date:  1963-03-30       Impact factor: 5.691

3.  On the specificity of broad spectrum agglutinins. IV. Invertebrate agglutinins: current status, conceptions and further observations on the variation of the Hel receptor in pigs.

Authors:  G Uhlenbruck; U Reifenberg; M Heggen
Journal:  Z Immunitatsforsch Allerg Klin Immunol       Date:  1970-06

4.  Studies on IgA. I. Fractionation procedure for isolation of IgA from pooled normal human plasma.

Authors:  R H Zschocke; H G Grieble; G L Bach; T O Anderson
Journal:  J Immunol       Date:  1969-03       Impact factor: 5.422

5.  Studies on the major sialoglycoprotein of the human red cell membrane. Isolation and characterization of tryptic glycopeptides.

Authors:  R L Jackson; J P Segrest; I Kahane; V T Marchesi
Journal:  Biochemistry       Date:  1973-07-31       Impact factor: 3.162

6.  Studies on specificity and binding properties of the blood group A reactive hemagglutinin from Helix pomatia.

Authors:  S Hammarström; E A Kabat
Journal:  Biochemistry       Date:  1971-04-27       Impact factor: 3.162

7.  A new source of antibody-like substances having anti-blood group specificity. A discussion on the specificity of Helix agglutinins.

Authors:  O Prokop; G Uhlenbruck; W Köhler
Journal:  Vox Sang       Date:  1968       Impact factor: 2.144

8.  Immunochemical studies on blood groups. 43. The interaction of blood group substances from various sources with a plant lectin, concanavalin A.

Authors:  K O Lloyd; E A Kabat; S Beychok
Journal:  J Immunol       Date:  1969-06       Impact factor: 5.422

9.  An enzymatic basis for secretor status and blood group substance specificity in humans.

Authors:  L Shen; E F Grollman; V Ginsburg
Journal:  Proc Natl Acad Sci U S A       Date:  1968-01       Impact factor: 11.205

10.  Differences in the H antigen on human buccal cells from secretor and non-secretor individuals.

Authors:  L L Flory
Journal:  Vox Sang       Date:  1966 Mar-Apr       Impact factor: 2.144

View more
  1 in total

1.  Secretory immunoglobulins in colonic neoplasms.

Authors:  P Weisz-Carrington; M E Poger; M E Lamm
Journal:  Am J Pathol       Date:  1976-11       Impact factor: 4.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.